We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$56.2B
AUM Growth
+$5.69B
(+11%)
Cap. Flow
-$410M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
3,692
New
183
Increased
1,286
Reduced
1,419
Closed
493
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.4M |
| 2 |
Sun Communities
SUI
|
+$68.7M |
| 3 |
Amazon
AMZN
|
+$68.5M |
| 4 |
Humana
HUM
|
+$62M |
| 5 |
APO.PRA
Apollo Global Management Series A
APO.PRA
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$51.7M |
| 3 |
Prologis
PLD
|
+$47.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$47.3M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.24% |
| 2 | Financials | 13% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Lexicon Pharmaceuticals
LXRX
$1.04B
| $75.1K | ﹤0.01% |
49,100
| – | – |
|
2502
ImmunityBio
IBRX
$8.11B
| $74.1K | ﹤0.01% |
14,766
+11,861
| +408% | +$37.2K |
|
|
EGRX
2503
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $73.9K | ﹤0.01% |
14,140
-1,325
| -9% | -$13.1K |
|
2504
BioNTech
BNTX
$23.1B
| $73.8K | ﹤0.01% |
699
-409
| -37% | -$41.2K |
|
|
TUYA
2505
Tuya Inc
TUYA
$1.12B
| $73.4K | ﹤0.01% |
+31,905
| New | +$58.9K |
|
2506
Strategic Education
STRA
$1.86B
| $72.9K | ﹤0.01% |
+789
| New | +$68.3K |
|
2507
TTEC Holdings
TTEC
$77.4M
| $71K | ﹤0.01% |
3,278
-78,976
| -96% | -$1.66M |
|
|
BFIN
2508
DELISTED
BankFinancial
BFIN
| $69.8K | ﹤0.01% |
6,800
| – | – |
|
2509
Regional Management Corp
RM
$301M
| $69.7K | ﹤0.01% |
2,781
-45,937
| -94% | -$1.11M |
|
2510
iShares US Healthcare ETF
IYH
$3.77B
| $68.5K | ﹤0.01% |
1,195
-810
| -40% | -$44.1K |
|
2511
Vivid Seats
SEAT
$80.5M
| $67.6K | ﹤0.01% |
535
-875
| -62% | -$120K |
|
2512
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
| $65.7K | ﹤0.01% |
174
-108
| -38% | -$37.7K |
|
2513
Iovance Biotherapeutics
IOVA
$2.95B
| $65.3K | ﹤0.01% |
8,035
-5,285
| -40% | -$27.7K |
|
|
XRN
2514
Chiron Real Estate Inc
XRN
$484M
| $64.8K | ﹤0.01% |
1,168
-3,374
| -74% | -$164K |
|
2515
CytomX Therapeutics
CTMX
$730M
| $64.7K | ﹤0.01% |
41,725
-3,901
| -9% | -$5.13K |
|
2516
NatWest
NWG
$76.9B
| $64.4K | ﹤0.01% |
11,438
-2,089
| -15% | -$11.1K |
|
2517
Atlanticus Holdings
ATLC
$1.47B
| $64K | ﹤0.01% |
1,654
| – | – |
|
2518
Nektar Therapeutics
NKTR
$2.57B
| $63.7K | ﹤0.01% |
7,518
-3,061
| -29% | -$23.2K |
|
2519
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $63.7K | ﹤0.01% |
712
| – | – |
|
2520
Sturm, Ruger & Co
RGR
$601M
| $63.1K | ﹤0.01% |
1,388
+104
| +8% | +$4.99K |
|
2521
Wendy's
WEN
$1.65B
| $62.7K | ﹤0.01% |
3,220
+586
| +22% | +$11.3K |
|
2522
Nomura Holdings
NMR
$29.2B
| $62.2K | ﹤0.01% |
13,798
+10,999
| +393% | +$45.2K |
|
2523
UNIFI
UFI
$120M
| $60.8K | ﹤0.01% |
9,131
-148,581
| -94% | -$969K |
|
2524
Coeur Mining
CDE
$19B
| $59.9K | ﹤0.01% |
18,381
-13,040
| -42% | -$35.6K |
|
2525
iShares Russell 3000 ETF
IWV
$20.6B
| $59.4K | ﹤0.01% |
217
-22
| -9% | -$5.61K |
|
Similar funds
Russell Investments Group's Q4 2023 Portfolio in Review
As of Q4 2023, Russell Investments Group held 3,692 positions worth $56.2B, up 11% from $50.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Russell Investments Group's Q4 2023 filing shows 183 new, 1,286 increased, 1,419 reduced and 493 closed positions. Its largest new stake was Veralto: 542,517 shares worth $44.6M. The largest sale was Bank of America Series L, an estimated $235M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Russell Investments Group's largest Q4 2023 buy was Veralto: 542,517 shares worth $44.6M.
- Russell Investments Group added most to Apple in Q4 2023, an estimated $92.4M increase.
- Russell Investments Group's biggest Q4 2023 reduction was Bank of America Series L, cutting an estimated $235M.
- Russell Investments Group fully exited Televisa in Q4 2023, selling an estimated $16.6M.
- Russell Investments Group's ten largest holdings make up 19% of its $56.2B portfolio in Q4 2023.
- Russell Investments Group opened 183 new positions and closed 493 in Q4 2023.
- Russell Investments Group's portfolio value rose 11% quarter-over-quarter to $56.2B.
Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.